Shandong Longli Biotechnology Co., Ltd. (hereinafter referred to as "the Company") received the Shenzhen Stock Exchange's decision on May 22, 2020, regarding the termination of the Company's stock listing (Shenzhen Stock Exchange [2020] No. 428). According to the relevant provisions of the "Shenzhen Stock Exchange Listing Rules (Revised November 2018)," the Company's stock will enter the delisting transition period trading on June 1, 2020. The relevant arrangements for the Company's stock during the delisting transition period are announced as follows:
002604SZSE
Announcement on the Company's Stock Entering the Delisting Transition Period Trading
✨ AI Summary
The announcement informs that the stock of Shandong Longli Biotechnology Co., Ltd. will enter a delisting transition period starting June 1, 2020, following a decision by the Shenzhen Stock Exchange. The transition period will last for thirty trading days, with the expected last trading date on July 14, 2020. During this period, the stock will have a price fluctuation limit of 10%.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.